Dassault Systèmes will acquire Accelrys, a provider of scientific innovation lifecycle management software for chemistry, biology and materials.
CIMdata sees this as a good move for Dassault Systèmes, one that was not too dear at 4.6 times revenues. It increases Dassault Systèmes’ addressable market, and is a good compliment to the ENOVIA offerings, including Enginuity.
Combining with Accelrys will enrich the molecular chemistry capabilities from discovery to manufacturing and regulatory requirements of Dassault Systèmes’ formulation-based industry offerings such as life sciences, consumer packaged goods, high tech and energy, as well as advanced manufacturing industries.
“The World demands a new paradigm for sustainability where chemistry, materials and biology meet. This is what the virtual universes enabled by Dassault Systèmes are delivering, capable of harmonizing products, nature and life, from imagination to industry solution experience,” said Bernard Charlès, President and CEO, Dassault Systèmes.
Accelrys’ list of 2,000 customers includes many of the Fortune 500 companies, with major industry players in pharma/biotech, consumer packaged goods and chemical including Sanofi, Pfizer, GSK, AstraZeneca, Du Pont, Shell, BASF, P&G, Unilever and L’Oréal.
[Image: Accelrys]